NYMOX PHARMACEUTICAL CORP (NYMX)
BSP733981026 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.88M | -6.58M | -12.54M | -11.74M | -13.16M | |||
| Depreciation Amortization | 12.00K | 12.00K | 12.00K | 10.00K | 10.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 44.00K | 495.00K | -140.00K | -310.00K | 830.00K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 835.00K | 864.00K | 2.85M | 2.01M | 4.90M | |||
| OPERATING CASH FLOW | -1.99M | -5.21M | -9.82M | -10.04M | -7.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.00K | 0.00 | -6.00K | -10.00K | 0.00 | |||
| INVESTING CASH FLOW | -3.00K | 0.00 | -6.00K | -10.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -231.00K | -229.00K | -238.00K | -270.00K | -280.00K | |||
| Stock Issued/Repurchased | 1.90M | 6.01M | 7.28M | 8.69M | 5.00M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 1.67M | 5.78M | 7.04M | 8.42M | 4.72M | |||
| CHANGE IN CASH | -321.00K | 573.00K | -2.78M | -1.63M | -2.71M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -1.99M | -5.21M | -9.82M | -10.04M | -7.43M | |||
| Capital Expenditure | -3.00K | 0.00 | -6.00K | -10.00K | 0.00 | |||
| FREE CASH FLOW | -1.99M | -5.21M | -9.83M | -10.05M | -7.43M | |||
All data in USD